Work

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4

Year: 2014

Type: article

Abstract: Meeting abstracts Biomarker studies used with immunotherapeutic strategies in the clinic have typically involved monitoring immunologic changes within the systemic circulation; however, recent data indicate that immunological changes within tumor tissues will be more likely to predict clinical

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-2-s2-i6

Author: P Sharma

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490